Divis Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹3,080.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.80 per cent from ₹2,831.00 crore. This corresponds to a year-on-year *(YoY) growth of 27.80 per cent.
Operating Profit
Operating Profit stands at ₹1,255.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.37 per cent from ₹934.00 crore. This corresponds to a year-on-year *(YoY) growth of 72.15 per cent.
PBDT
PBDT stands at ₹1,313.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,083.00 crore. This corresponds to a year-on-year *(YoY) growth of 55.38 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,180.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 22.53 per cent from ₹963.00 crore. This corresponds to a year-on-year *(YoY) growth of 60.98 per cent.
Net Profit
Net Profit stands at ₹902.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.11 per cent from ₹751.00 crore. This represents a 65.50 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Divis Laboratories Ltd News
Divis Laboratories Ltd Earnings
- YOY
- QOQ
Divis Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Divis Laboratories Ltd Research Reports
Divis Laboratories Ltd Financial Reports
Divis Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Divi's Lab. | 1.24% | 1.18% | 17.46% | 24.76% | 36.68% | 43.21% |
| Sun Pharma.Inds. | -0.32% | -3.42% | -4.08% | -0.22% | 8.81% | 14.79% |
| Torrent Pharma. | 1.63% | 2.02% | -0.56% | 12.31% | 17.40% | 35.82% |
| Cipla | 0.13% | -2.00% | -0.67% | 2.31% | 6.74% | -7.37% |
| Zydus Lifesci. | -1.33% | -4.77% | -2.59% | 7.31% | 23.97% | 13.63% |
Company Info
Company Information
Chairman & Independent Directo : Ramesh B V Nimmagadda
Executive Director & MD : Murali K Divi
Executive Director : N V Ramana
Executive Director / Whole Time Director / CEO : Kiran S Divi
ED / WTD - Commercial : Nilima Prasad Divi
Executive Director / Whole Time Director : S. Devendra Rao
Independent Non Exe. Director : S Ganapaty
Independent Non Exe. Director : Sunaina Singh
Independent Non Exe. Director : Kosaraju Veerayya Chowdary
Independent Non Exe. Director : Rajendrakumar Premchand Shah
Company Sec. & Compli. Officer : Satish Choudhury